Circular RNA expression in cutaneous squamous cell carcinoma

Journal of Dermatological Science

Volumn 83, Issue 3, 2016, Pages 210-218

  Sand, Michael ^a,b   Bechara, Falk G ^a   Gambichler, Thilo ^a   Sand, Daniel ^c   Bromba, Michael ^b   Hahn, Stephan A ^a   Stockfleth, Eggert ^a   Hessam, Schapoor ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

CircularRNAs; Cutaneous squamous cell carcinoma; MicroRNAs; Non coding RNAs

Indexed keywords

CIRCULAR RNA; MICRORNA; RNA; UNCLASSIFIED DRUG; RNA, CIRCULAR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA MINING; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; RNA RESPONSE ELEMENT; RNA STRUCTURE; SEQUENCE ANALYSIS; SKIN CARCINOMA; UPREGULATION; VERY ELDERLY; BIOLOGY; CASE CONTROL STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; PATHOLOGY; PROCEDURES; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, NEOPLASM; SKIN NEOPLASMS;

EID: 84991063637     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2016.05.012     Document Type: Article

References (61)

1. [1] Breuninger, H.S.G., Kortmann, R.D., Wolff, K., Bootz, F., Garbe, C., Deutsche Leitlinie Plattenepithelkarzinome der Haut, der Lippen und der Augenlider. Garbe, C., (eds.) Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hauttumoren, 2005, Georg Thieme Verlag, Stuttgart, 12–22.
2. [2] Sand, M., Gambichler, T., Sand, D., Skrygan, M., Altmeyer, P., Bechara, F.G., MicroRNAs and the skin: tiny players in the body's largest organ. J. Dermatol. Sci. 53 (2009), 169–175.
3. [3] Sand, M., Sand, D., Altmeyer, P., Bechara, F.G., MicroRNA in non-melanoma skin cancer. Cancer Biomarkers 11 (2012), 253–257.
4. [4] Sand, M., Gambichler, T., Skrygan, M., Sand, D., Scola, N., Altmeyer, P., et al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest. 28 (2010), 649–653.
5. [5] Sand, M., Skrygan, M., Georgas, D., Arenz, C., Gambichler, T., Sand, D., et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol. Carcinog. 51 (2012), 916–922.
6. [6] Sand, M., Skrygan, M., Georgas, D., Sand, D., Hahn, S.A., Gambichler, T., et al. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. J. Dermatol. Sci. 68 (2012), 119–126.
7. [7] Dziunycz, P., Iotzova-Weiss, G., Eloranta, J.J., Lauchli, S., Hafner, J., French, L.E., et al. Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. J. Invest. Dermatol. 130 (2010), 2686–2689.
8. [8] Xu, N., Zhang, L., Meisgen, F., Harada, M., Heilborn, J., Homey, B., et al. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J. Biol. Chem. 287 (2012), 29899–29908.
9. [9] Kim, B.K., Kim, I., Yoon, S.K., Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma. J. Dermatol. Sci. 79 (2015), 137–147.
10. [10] Olasz, E.B., Seline, L.N., Schock, A.M., Duncan, N.E., Lopez, A., Lazar, J., et al. MicroRNA-135b regulates leucine zipper tumor suppressor 1 in cutaneous squamous cell carcinoma. PLoS One, 2015, e0125412.
11. [11] Wang, A., Landen, N.X., Meisgen, F., Lohcharoenkal, W., Stahle, M., Sonkoly, E., et al. MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells. PLoS One, 9, 2014, e103206.
12. [12] Zhou, J., Liu, R., Luo, C., Zhou, X., Xia, K., Chen, X., et al. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1. Cancer Biol. Ther. 15 (2014), 1340–1349.
13. [13] Gastaldi, C., Bertero, T., Xu, N., Bourget-Ponzio, I., Lebrigand, K., Fourre, S., et al. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma. Carcinogenesis 35 (2014), 1110–1120.
14. [14] Li, J., Yang, J., Zhou, P., Le, Y., Zhou, C., Wang, S., et al. Circular RNAs in cancer: novel insights into origins, properties, functions and implications. Am J Cancer Res. 5 (2015), 472–480.
15. [15] Bachmayr-Heyda, A., Reiner, A.T., Auer, K., Sukhbaatar, N., Aust, S., Bachleitner-Hofmann, T., et al. Correlation of circular RNA abundance with proliferation-exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci. Rep., 5(8057), 2015.
16. [16] Nigro, J.M., Cho, K.R., Fearon, E.R., Kern, S.E., Ruppert, J.M., Oliner, J.D., et al. Scrambled exons. Cell 64 (1991), 607–613.
17. [17] Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., et al. Natural RNA circles function as efficient microRNA sponges. Nature 495 (2013), 384–388.
18. [18] Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495 (2013), 333–338.
19. [19] Wilusz, J.E., Sharp, P.A., Molecular biology. A circuitous route to noncoding RNA. Science 340 (2013), 440–441.
20. [20] Wang, P.L., Bao, Y., Yee, M.C., Barrett, S.P., Hogan, G.J., Olsen, M.N., et al. Circular RNA is expressed across the eukaryotic tree of life. PloS One, 9, 2014, e90859.
21. [21] Salzman, J., Gawad, C., Wang, P.L., Lacayo, N., Brown, P.O., Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One, 7, 2012, e30733.
22. [22] Hansen, T.B., Kjems, J., Damgaard, C.K., Circular RNA and miR-7 in cancer. Cancer Res. 73 (2013), 5609–5612.
23. [23] Salzman, J., Chen, R.E., Olsen, M.N., Wang, P.L., Brown, P.O., Cell-type specific features of circular RNA expression. PLoS Genet., 2013, e1003777.
24. [24] Zhang, Y., Zhang, X.O., Chen, T., Xiang, J.F., Yin, Q.F., Xing, Y.H., et al. Circular intronic long noncoding RNAs. Mol. Cell 51 (2013), 792–806.
25. [25] Zhang, X.O., Wang, H.B., Zhang, Y., Lu, X., Chen, L.L., Yang, L., Complementary sequence-mediated exon circularization. Cell 159 (2014), 134–147.
26. [26] Jeck, W.R., Sorrentino, J.A., Wang, K., Slevin, M.K., Burd, C.E., Liu, J., et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19 (2013), 141–157.
27. [27] Guo, J.U., Agarwal, V., Guo, H., Bartel, D.P., Expanded identification and characterization of mammalian circular RNAs. Genome Biol., 15(409), 2014.
28. [28] Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., Golani, I., Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125 (2001), 279–284.
29. [29] Quackenbush, J., Computational analysis of microarray data. Nat. Rev. Genet. 2 (2001), 418–427.
30. [30] Sokal, R.R., Michener, C.D., A statistical method for evaluating systematic relationships. Univ. Kansas Sci. Bull. 28 (1958), 1409–1438.
31. [31] Glazar, P., Papavasileiou, P., Rajewsky, N., circBase: a database for circular RNAs. RNA 20 (2014), 1666–1670.
32. [32] Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
33. [33] Enright, A.J., John, B., Gaul, U., Tuschl, T., Sander, C., Marks, D.S., MicroRNA targets in drosophila. Genome Biol., 1, 2003.
34. [34] John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., Marks, D.S., Human MicroRNA targets. PLoS Biol., 63, 2004.
35. [35] Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P., Bartel, D.P., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27 (2007), 91–105.
36. [36] Syed, D.N., Lall, R.K., Mukhtar, H., MicroRNAs and photocarcinogenesis. Photochem. Photobiol. 91 (2015), 173–187.
37. [37] Peng, L., Yuan, X.Q., Li, G.C., The emerging landscape of circular RNA ciRS-7 in cancer (Review). Oncol. Rep. 33 (2015), 2669–2674.
38. [38] Li, P., Chen, S., Chen, H., Mo, X., Li, T., Shao, Y., et al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin. Chim. Acta 444 (2015), 132–136.
39. [39] Mura, M., Hopkins, T.G., Michael, T., Abd-Latip, N., Weir, J., Aboagye, E., et al. LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene, 2014.
40. [40] Liang, H., Cheung, L.W., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res. 22 (2012), 2120–2129.
41. [41] He, Y., Blackford, J.A. Jr., Kohn, E.C., Simons, S.S. Jr., STAMP alters the growth of transformed and ovarian cancer cells. BMC Cancer, 10(128), 2010.
42. [42] Bianchini, M., Levy, E., Zucchini, C., Pinski, V., Macagno, C., De Sanctis, P., et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int. J. Oncol. 29 (2006), 83–94.
43. [43] Konialis, C., Savola, S., Karapanou, S., Markaki, A., Karabela, M., Polychronopoulou, S., et al. Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics. Hematology 19 (2014), 217–224.
44. [44] Jee, H.J., Kim, H.J., Kim, A.J., Song, N., Kim, M., Lee, H.J., et al. The inhibition of Nek6 function sensitizes human cancer cells to premature senescence upon serum reduction or anticancer drug treatment. Cancer Lett. 335 (2013), 175–182.
45. [45] Uhlen, M., Bjorling, E., Agaton, C., Szigyarto, C.A., Amini, B., Andersen, E., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell. Proteomics 4 (2005), 1920–1932.
46. [46] Park, W.J., Kothapalli, K.S., Lawrence, P., Brenna, J.T., FADS2 function loss at the cancer hotspot 11q13 locus diverts lipid signaling precursor synthesis to unusual eicosanoid fatty acids. PLoS One, 8186, 2011.
47. [47] Park, H.G., Kothapalli, K., Park, W.J., Qin, X., Lawrence, P., Brenna, J., Human breast cancer cells stably expressed FADS2 synthesize sapienic acid (16: 1n-10) from palmitic acid (16: 0)(821. 8). FASEB J. 28 (2014), 821–828.
48. [48] Gotoh, M., Ichikawa, H., Arai, E., Chiku, S., Sakamoto, H., Fujimoto, H., et al. Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis. Genes. Chromosomes Cancer 53 (2014), 1018–1032.
49. [49] Coutinho-Camillo, C.M., Salaorni, S., Sarkis, A.S., Nagai, M.A., Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. Cancer Genet. Cytogenet. 166 (2006), 130–138.
50. [50] Zhang, S., Guo, D., Luo, W., Zhang, Q., Zhang, Y., Li, C., et al. TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. BMC Cancer, 10(43), 2010.
51. [51] Khakpour, G., Pooladi, A., Izadi, P., Noruzinia, M., Tavakkoly Bazzaz, J., DNA methylation as a promising landscape: a simple blood test for breast cancer prediction. Tumour Biol. 36 (2015), 4905–4912.
52. [52] De Keersmaecker, K., Porcu, M., Cox, L., Girardi, T., Vandepoel, R., de Beeck, J.O., et al. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. Haematologica 99 (2014), 85–93.
53. [53] Campan, M., Moffitt, M., Houshdaran, S., Shen, H., Widschwendter, M., Daxenbichler, G., et al. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One, 8141, 2011.
54. [54] Yu, D., Li, Z., Gan, M., Zhang, H., Yin, X., Tang, S., et al. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients. Tumour Biol., 2015.
55. [55] Hapgood, G., Savage, K.J., The biology and management of systemic anaplastic large cell lymphoma. Blood 126 (2015), 17–25.
56. [56] Xing, X., Feldman, A.L., Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Adv. Anat. Pathol. 22 (2015), 29–49.
57. [57] Laurin, M., Huber, J., Pelletier, A., Houalla, T., Park, M., Fukui, Y., et al. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 7434–7439.
58. [58] Shah, P.P., Fong, M.Y., Kakar, S.S., PTTG induces EMT through integrin alphaVbeta3-focal adhesion kinase signaling in lung cancer cells. Oncogene 31 (2012), 3124–3135.
59. [59] Feng, H., Li, Y., Yin, Y., Zhang, W., Hou, Y., Zhang, L., et al. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor alpha. Neuro Oncol. 17 (2015), 832–842.
60. [60] Zhao, F., Siu, M.K., Jiang, L., Tam, K.F., Ngan, H.Y., Le, X.F., et al. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival. Histopathology 59 (2011), 1163–1172.
61. [61] Yang, J.J., Cho, L.Y., Ma, S.H., Ko, K.P., Shin, A., Choi, B.Y., et al. Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study. PLoS One, 2011, e21155.